LYTAP-001

N/A

Report date: 2026/04/29 20:02:18
NME

Base Information

Drug NameLYTAP-001
Drug Alias NameLYTAP-001
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFilamon Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFilamon Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A